pillbase.ru

Nerlynx

Active substance: neratinib

TABLET · NERATINIB MALEATE ANHYDROUS 40 mg/1

United StatesActive

Marketing holder: Puma Biotechnology, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Nerlynx
    neratinib
    EMEA/H/C/004030
    Pierre Fabre Medicament
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-d813-7d03-be6b-09718331d733,01a12097-da0f-7130-af12-d3508e02fb04;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
70437-240
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 70437-240 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 70437-240 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 70437-240 · Verified 2026-10-09 · open in source